India's First Indigenous Omicron-Specific Booster Vaccine Approved oneindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from oneindia.com Daily Mail and Mail on Sunday newspapers.
India News: NEW DELHI: India's drug controller has granted emergency use authorisation for the Omicron-specific mRNA-based booster vaccine developed by Gennova Bi.
Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology orissadiary.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orissadiary.com Daily Mail and Mail on Sunday newspapers.
Govt Gives Nod For Covid-19 Omicron-Specific mRNA-Based Vaccine outlookindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outlookindia.com Daily Mail and Mail on Sunday newspapers.
Gennova Biopharmaceuticals mRNA Covid-19 booster vaccine, Gemcovac Om , has received emergency use authorisation from the office of the Drugs Controller General of India for the Omicron variant. The vaccine is the first booster Covid-19 vaccine developed in India against the highly transmissible Omicron variant and has demonstrated robust immune responses in phase 3 clinical trials. It is stable at two to eight degrees Centigrade and has been developed using Gennova s indigenous platform technology, supported under Mission Covid Suraksha .